Scheduling-dependent interaction for the combination of cytosine arabinoside and daunorubicin on HL-60 cells.
Bernabei
P A
PA
Rombolà
G
G
Saccardi
R
R
Bezzini
R
R
Santini
V
V
Pifferi
C
C
Gattei
V
V
Ferrini
P R
PR
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D003561:Cytarabine; D003630:Daunorubicin